Qube Research & Technologies (QRT)
RXST icon

Qube Research & Technologies (QRT)’s RxSight RXST Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Buy
491,550
+366,420
+293% +$2.21M ﹤0.01% 2048
2026
Q1 		$771K Buy
+125,130
New +$1.04M ﹤0.01% 2601
2025
Q3 		– Sell
-386,210
Closed -$5.02M – 3898
2025
Q2 		$5.02M Buy
386,210
+63,187
+20% +$950K 0.01% 1691
2025
Q1 		$8.16M Buy
323,023
+114,080
+55% +$3.39M 0.01% 1259
2024
Q4 		$7.18M Buy
208,943
+67,275
+47% +$3.03M 0.01% 1300
2024
Q3 		$7M Sell
141,668
-11,234
-7% -$576K 0.01% 1234
2024
Q2 		$9.2M Sell
152,902
-35,551
-19% -$2.03M 0.01% 955
2024
Q1 		$9.72M Buy
188,453
+146,871
+353% +$7.21M 0.02% 863
2023
Q4 		$1.68M Buy
+41,582
New +$1.22M ﹤0.01% 1623
2023
Q3 		– Sell
-7,297
Closed -$210K – 4294
2023
Q2 		$210K Buy
+7,297
New +$162K ﹤0.01% 1766

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RXST Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its RxSight (RXST) stake by 293% in Q2 2026, buying an estimated $2.21M and bringing the position to 491,550 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

Qube Research & Technologies (QRT) first reported a position in RXST in Q2 2023 and has held it in 10 quarters since. The position peaked at $9.72M in Q1 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Qube Research & Technologies (QRT) held 491,550 shares of RxSight worth $2.37M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 366,420 RxSight shares in Q2 2026, an estimated $2.21M.
  • RxSight made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2048 holding.
  • Qube Research & Technologies (QRT) first reported a position in RxSight in Q2 2023 and has held it in 10 quarters since.
  • Qube Research & Technologies (QRT)'s RxSight position peaked at $9.72M in Q1 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.